ArticleHealth science reports2025
The Prevalence of Toxoplasmosis Antibodies Among Pregnant Women Attending Antenatal Care Services in Urban and Rural Health Facilities in Three Regions of Burkina Faso: A Cross-Sectional Study.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Congenital toxoplasmosis can cause severe diseases to the fetus and newborns or abortion, and is associated with significant morbidity and mortality. In Burkina Faso, while seroprevalence data for toxoplasmosis are available for urban areas, such data are scarce for rural areas. This study aims to determine the seroprevalence of toxoplasmosis in pregnant women attending antenatal services in primary health facilities in rural and urban areas. Methods: A cross-sectional study was conducted between July 2022 and June 2023 in health facilities located in the Cascades ( Results: A total of 2509 pregnant women were enrolled and screened. Their mean age was 25.71 years, and the overall seroprevalence (IgM-positive and or IgG-positive) was 29.33% (736) (95% CI: 27.56-31.16). Of the 736 women tested positive for both antibodies, 27 were seropositive for IgM antibody; 703 for IgG antibody and 6 for both antibody (Ig M; Ig G). No statistically differences were observed in the seroprevalence according to age, place of residence (rural, urban), and educational level of the participant ( Conclusion: The results of our study indicate a high seroprevalence of toxoplasmosis among pregnant women, with no statistically difference between rural and urban areas. Some women acquired the infection during pregnancy, underscoring the risk of congenital toxoplasmosis. Health authorities should integrate toxoplasmosis diagnosis into a free antenatal screening program to facilitate the detection of toxoplasmosis during pregnancy and prevent congenital toxoplasmosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.